• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A.环磷酸腺苷依赖性蛋白激酶A对组蛋白去乙酰化酶8活性的负调控
Mol Cell Biol. 2004 Jan;24(2):765-73. doi: 10.1128/MCB.24.2.765-773.2004.
2
Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation.组蛋白去乙酰化酶8保护人类端粒不断缩短蛋白1B(hEST1B)免受泛素介导的降解。
Mol Cell Biol. 2006 Jul;26(14):5259-69. doi: 10.1128/MCB.01971-05.
3
Cloning and characterization of a novel human histone deacetylase, HDAC8.一种新型人类组蛋白去乙酰化酶HDAC8的克隆与鉴定
Biochem J. 2000 Aug 15;350 Pt 1(Pt 1):199-205.
4
Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor.一种作为转录抑制因子发挥作用的新型人类I类组蛋白去乙酰化酶的克隆与特性分析。
J Biol Chem. 2000 May 19;275(20):15254-64. doi: 10.1074/jbc.M908988199.
5
Class II histone deacetylases: structure, function, and regulation.II类组蛋白去乙酰化酶:结构、功能及调控
Biochem Cell Biol. 2001;79(3):243-52.
6
Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.组蛋白去乙酰化酶1/mSin3A破坏γ干扰素诱导的CIITA功能以及主要组织相容性复合体II类增强体的形成。
Mol Cell Biol. 2003 May;23(9):3091-102. doi: 10.1128/MCB.23.9.3091-3102.2003.
7
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.人类HDAC8的结构快照为I类组蛋白去乙酰化酶提供了深入见解。
Structure. 2004 Jul;12(7):1325-34. doi: 10.1016/j.str.2004.04.012.
8
Transcription regulation mechanism of the syntaxin 1A gene via protein kinase A.Syntaxin 1A基因通过蛋白激酶A的转录调控机制
Biochem J. 2017 Jul 11;474(14):2465-2473. doi: 10.1042/BCJ20170249.
9
Regulation of histone deacetylase 2 by protein kinase CK2.蛋白激酶CK2对组蛋白去乙酰化酶2的调控
J Biol Chem. 2002 Aug 30;277(35):31826-33. doi: 10.1074/jbc.M204149200. Epub 2002 Jun 24.
10
Phosphorylation of Histone Deacetylase 8: Structural and Mechanistic Analysis of the Phosphomimetic S39E Mutant.组蛋白去乙酰化酶 8 的磷酸化:磷酸模拟 S39E 突变体的结构和机制分析。
Biochemistry. 2019 Nov 12;58(45):4480-4493. doi: 10.1021/acs.biochem.9b00653. Epub 2019 Nov 4.

引用本文的文献

1
Reversible acetylation of HDAC8 regulates cell cycle.HDAC8 的可逆乙酰化调节细胞周期。
EMBO Rep. 2024 Sep;25(9):3925-3943. doi: 10.1038/s44319-024-00210-w. Epub 2024 Jul 23.
2
Inhibition of HDAC8 Reduces the Proliferation of Adult Neural Stem Cells in the Subventricular Zone.抑制组蛋白去乙酰化酶8可减少脑室下区成年神经干细胞的增殖。
Int J Mol Sci. 2024 Feb 22;25(5):2540. doi: 10.3390/ijms25052540.
3
Sodium butyrate ameliorates high glucose-suppressed neuronal mitophagy by restoring PRKN expression via inhibiting the RELA-HDAC8 complex.丁酸钠通过抑制 RELA-HDAC8 复合物恢复 PRKN 表达来改善高糖抑制的神经元线粒体自噬。
Autophagy. 2024 Jul;20(7):1505-1522. doi: 10.1080/15548627.2024.2323785. Epub 2024 Mar 6.
4
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis.HDAC8 介导的 EP300 抑制作用驱动了一种转录状态,增加了黑色素瘤脑转移。
Nat Commun. 2023 Nov 29;14(1):7759. doi: 10.1038/s41467-023-43519-1.
5
Exploring the Potential of Phytocompounds for Targeting Epigenetic Mechanisms in Rheumatoid Arthritis: An In Silico Study Using Similarity Indexing.探讨植物化合物靶向类风湿关节炎表观遗传机制的潜力:基于相似度索引的体外研究。
Molecules. 2023 Mar 7;28(6):2430. doi: 10.3390/molecules28062430.
6
Therapeutic Efficacy of Novel HDAC Inhibitors SPA3052 and SPA3074 against Intestinal Inflammation in a Murine Model of Colitis.新型组蛋白去乙酰化酶抑制剂SPA3052和SPA3074对小鼠结肠炎模型肠道炎症的治疗效果
Pharmaceuticals (Basel). 2022 Dec 5;15(12):1515. doi: 10.3390/ph15121515.
7
Pathological Role of HDAC8: Cancer and Beyond.HDAC8 的病理作用:癌症及其他。
Cells. 2022 Oct 9;11(19):3161. doi: 10.3390/cells11193161.
8
Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs).基于结构的 I 类组蛋白去乙酰化酶(HDACs)抑制剂发现。
Int J Mol Sci. 2020 Nov 22;21(22):8828. doi: 10.3390/ijms21228828.
9
HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia.组蛋白去乙酰化酶8:急性髓系白血病的一个有前景的治疗靶点。
Front Cell Dev Biol. 2020 Sep 4;8:844. doi: 10.3389/fcell.2020.00844. eCollection 2020.
10
Bifunctional HDAC Therapeutics: One Drug to Rule Them All?双功能 HDAC 治疗剂:一种药物能统治一切吗?
Molecules. 2020 Sep 24;25(19):4394. doi: 10.3390/molecules25194394.

本文引用的文献

1
Histone deacetylases: unique players in shaping the epigenetic histone code.组蛋白去乙酰化酶:塑造表观遗传组蛋白密码的独特因子。
Ann N Y Acad Sci. 2003 Mar;983:84-100. doi: 10.1111/j.1749-6632.2003.tb05964.x.
2
Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression.组蛋白去乙酰化酶在调节染色质结构和基因表达中的协作精神。
Curr Opin Genet Dev. 2003 Apr;13(2):143-53. doi: 10.1016/s0959-437x(03)00015-7.
3
Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex.组蛋白去乙酰化酶-蛋白磷酸酶1复合物对磷酸化依赖性激活剂的衰减作用。
Nat Struct Biol. 2003 Mar;10(3):175-81. doi: 10.1038/nsb895.
4
The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain.inv(16)融合蛋白通过平滑肌肌球蛋白重链结构域与共抑制因子结合。
Mol Cell Biol. 2003 Jan;23(2):607-19. doi: 10.1128/MCB.23.2.607-619.2003.
5
Histone deacetylase inhibitors: from target to clinical trials.组蛋白去乙酰化酶抑制剂:从靶点到临床试验
Expert Opin Investig Drugs. 2002 Dec;11(12):1695-713. doi: 10.1517/13543784.11.12.1695.
6
The complexity of chromatin remodeling and its links to cancer.染色质重塑的复杂性及其与癌症的联系。
Biochim Biophys Acta. 2002 Oct 2;1603(1):19-29. doi: 10.1016/s0304-419x(02)00067-7.
7
The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2.转录抑制因子Sp3与CK2磷酸化的组蛋白去乙酰化酶2相关。
J Biol Chem. 2002 Sep 27;277(39):35783-6. doi: 10.1074/jbc.C200378200. Epub 2002 Aug 9.
8
Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation.配体诱导及p38介导的受体磷酸化对雌激素受体核输出的调控
Mol Cell Biol. 2002 Aug;22(16):5835-45. doi: 10.1128/MCB.22.16.5835-5845.2002.
9
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer.组蛋白去乙酰化酶抑制剂:用于治疗癌症的新型药物。
Nat Rev Drug Discov. 2002 Apr;1(4):287-99. doi: 10.1038/nrd772.
10
Protein kinase A signaling: "cross-talk" with other pathways in endocrine cells.蛋白激酶A信号传导:与内分泌细胞中其他信号通路的“串扰”
Ann N Y Acad Sci. 2002 Jun;968:256-70. doi: 10.1111/j.1749-6632.2002.tb04340.x.

环磷酸腺苷依赖性蛋白激酶A对组蛋白去乙酰化酶8活性的负调控

Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A.

作者信息

Lee Heehyoung, Rezai-Zadeh Natalie, Seto Edward

机构信息

H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

出版信息

Mol Cell Biol. 2004 Jan;24(2):765-73. doi: 10.1128/MCB.24.2.765-773.2004.

DOI:10.1128/MCB.24.2.765-773.2004
PMID:14701748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC343812/
Abstract

Histone deacetylases (HDACs) are enzymes that catalyze the removal of acetyl groups from lysine residues of histone and nonhistone proteins. Recent studies suggest that they are key regulators of many cellular events, including cell proliferation and cancer development. Human class I HDACs possess homology to the yeast RPD3 protein and include HDAC1, HDAC2, HDAC3, and HDAC8. While HDAC1, HDAC2, and HDAC3 have been characterized extensively, almost nothing is known about HDAC8. Here we report that HDAC8 is phosphorylated by cyclic AMP-dependent protein kinase A (PKA) in vitro and in vivo. The PKA phosphoacceptor site of HDAC8 is Ser(39), a nonconserved residue among class I HDACs. Mutation of Ser(39) to Ala enhances the deacetylase activity of HDAC8. In contrast, mutation of Ser(39) to Glu or induction of HDAC8 phosphorylation by forskolin, a potent activator of adenyl cyclase, decreases HDAC8's enzymatic activity. Remarkably, inhibition of HDAC8 activity by hyperphosphorylation leads to hyperacetylation of histones H3 and H4, suggesting that PKA-mediated phosphorylation of HDAC8 plays a central role in the overall acetylation status of histones.

摘要

组蛋白去乙酰化酶(HDACs)是一类催化从组蛋白和非组蛋白的赖氨酸残基上去除乙酰基的酶。最近的研究表明,它们是许多细胞事件的关键调节因子,包括细胞增殖和癌症发展。人类I类HDACs与酵母RPD3蛋白具有同源性,包括HDAC1、HDAC2、HDAC3和HDAC8。虽然HDAC1、HDAC2和HDAC3已被广泛研究,但关于HDAC8几乎一无所知。在此我们报告,HDAC8在体外和体内均被环磷酸腺苷依赖性蛋白激酶A(PKA)磷酸化。HDAC8的PKA磷酸化位点是Ser(39),这是I类HDACs中一个非保守残基。将Ser(39)突变为丙氨酸可增强HDAC8的去乙酰化酶活性。相反,将Ser(39)突变为谷氨酸或用强效腺苷酸环化酶激活剂福斯可林诱导HDAC8磷酸化,会降低HDAC8的酶活性。值得注意的是,HDAC8过度磷酸化导致的活性抑制会导致组蛋白H3和H4的过度乙酰化,这表明PKA介导的HDAC8磷酸化在组蛋白的整体乙酰化状态中起核心作用。